Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants


Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 - More infoView PDF  Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19.…[...]

Bivalent Covid-19 Vaccines — A Cautionary Tale.


List of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or…[...]

What COVID-19 variants are going around in November 2022?


Authors: Nebraska Medicine November 1, 2022 There are currently more than 37,000 cases reported in the United States per day, with test positivity of 8.6%. When test positivity is above 5%,…[...]

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection


Authors: Julie Boucau, Ph.D. Caitlin Marino, B.S. Ragon Institute, Cambridge, MA James Regan, B.S. Brigham and Women’s Hospital, Boston, MA Rockib Uddin, B.S.Massachusetts General Hospital, Boston, MA Manish C. Choudhary,…[...]

New coronavirus subvariants escape antibodies from vaccination and prior Omicron infection, studies suggest


Authors: Jacqueline Howard, CNN June 23, 2022 Omicron subvariants BA.4 and BA.5 appear to escape antibody responses among both people who had previous Covid-19 infection and those who have been fully…[...]